Completed PHASE1 INTERVENTIONAL 2-arm NCT01168245

TMS Stimulation and Cognitive Training in Alzheimer Patients

Effects of a Combined TMS Stimulation and Cognitive Training in Alzheimer Patients: a Single-center, Randomized, Double-blind, Placebo-controlled Study

Sponsor: Assaf-Harofeh Medical Center

Conditions Alzheimer Disease Mild to Moderate

Interventions NICE-System Sham-NICE-System

Updated 5 times since 2017 Last updated: Mar 26, 2013 Started: Jan 31, 2010 Primary completion: Sep 30, 2011 Completion: Sep 30, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1 trial investigates Alzheimer Disease and Mild to Moderate and is currently completed. Assaf-Harofeh Medical Center leads this study, which shows 5 recorded versions since 2010 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1
Jan 2017 — Jun 2018 [monthly]

Completed PHASE1

First recorded

Jan 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Assaf-Harofeh Medical Center
Neuronix Ltd

Data source: Neuronix Ltd

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Beer Yaakov, Israel